News dal mondo
07
Apr
Trump tariff order pushes onshore drug manufacturing longer term: analysts
Leerink Partners analysts see no near-term material changes to U.S. onshoring narrative, given Trump’s executive order late last week on pharmaceutical imports....[PharmaManufacturing]
30
AIFA pubblica il Terzo Position Paper sui farmaci biosimilari
È online il terzo Position Paper AIFA sui farmaci biosimilari. L’aggiornamento del documento...
29
US GDUFA IV Talks Reach Tentative Agreement; America First Application Fee Waiver Added
US FDA GDUFA Reauthorization performance goals and program enhancements Riscal years 2023-2027 - Meeting...
28
Sun Pharma compra Organon
Sun Pharmaceutical Industries ha firmato un accordo definitivo per acquisire Organon &...
27
US QMM: Participants scored well on commitment to quality, lower on advanced manufacturing
Pharmaceutical companies participating in the US Food and Drug Administration (FDA) Quality Maturity...
le ultime news
10 Apr
Contract manufacturing deals for drugs marketed in US shift to Europe
09 Apr
AIFA rafforza il dialogo con gli stakeholder: approvati due nuovi regolamenti
US-Iran ceasefire provides potential relief for pharma logistics, cost structures
07 Apr
Trump signs order imposing 100% tariff on patented pharmaceuticals, ingredients
02 Apr
AIFA - Aggiornamento Tariffe ISTAT dal 1 aprile 2026
AIFA - Per la prima volta i vertici in missione istituzionale in Giappone
27 Mar
EDQM shares guidance on reliance-based and fast-track CEP filings
<<<2 3 4>>>
